Turing Pharmaceuticals

Several witnesses in a securities fraud case against pharmaceutical executive Martin Shkreli are concerned he will retaliate if they testify against him, U.S. prosecutors say in a court filing.

A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill this week, as lawmakers took turns blasting the price-hiking former CEO who has become the new poster child for corporate greed.

A boyish-looking entrepreneur who became the new face of corporate greed when he jacked up the price of a lifesaving drug fiftyfold was led away in handcuffs by the FBI on unrelated fraud charges Thursday in a scene that left more than a few Americans positively gleeful.

A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines.

Several witnesses in a securities fraud case against pharmaceutical executive Martin Shkreli are concerned he will retaliate if they testify against him, U.S. prosecutors say in a court filing.

A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill this week, as lawmakers took turns blasting the price-hiking former CEO who has become the new poster child for corporate greed.

A boyish-looking entrepreneur who became the new face of corporate greed when he jacked up the price of a lifesaving drug fiftyfold was led away in handcuffs by the FBI on unrelated fraud charges Thursday in a scene that left more than a few Americans positively gleeful.

A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines.